Wutah pendapatan taun lumaku: Bionomics Limited (BNOX)

Tandha merek bionomics.com.au (BNOX)

The minimal environmental footprint of Bionomics Limited (BNOX) does not impact its share price; consequently, the TTM annual revenue growth reflects a metric level of -91.60. The asset's price action relies on the independence of neuropharmaceuticals from economic cycles. However, potential clinical trial failures and an acute need for continuous external financing due to the lack of commercial products pose a serious threat.

Bionomics (BNOX): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

bionomics.com.au (BNOX) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:Bionomics Limited
Produk sing diprodhuksi Bionomics Limited

This indicator measures the percentage change in revenue over the trailing twelve months, allowing for an assessment of the business's fundamental stability and the pace of its market share expansion. By analyzing the year-over-year (LTM) gross revenue dynamics on the GURU.Markets platform, Bionomics Limited (BNOX) investors can confirm the effectiveness of the biopharmaceutical licensing model, where growth in royalty income against fixed R&D costs ensures high profit scalability.